Cargando…

Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysis

PURPOSE: Circulating cell-free DNA (cfDNA) has been reported to predict outcomes in patients with various types of cancer. However, its prognostic value in patients with breast cancer is not well established still now. In this meta-analysis, we evaluated the prognostic role of cfDNA in breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jing, Cheng, Li, Zhang, Jing, Chen, Linyan, Wang, Denian, Guo, Xinli, Ma, Xuelei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076113/ https://www.ncbi.nlm.nih.gov/pubmed/29995790 http://dx.doi.org/10.1097/MD.0000000000011417

Ejemplares similares

Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis
por: Lin, Ziqiang, et al.
Publicado: (2017)

Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis
por: Yu, Dandan, et al.
Publicado: (2019)

The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis
por: Tan, Guoqiang, et al.
Publicado: (2018)

Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis
por: Li, Qingfang, et al.
Publicado: (2017)

Prognostic value of (18)F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis
por: Chen, Linyan, et al.
Publicado: (2017)

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma
por: Wintachai, Preawwalee, et al.
Publicado: (2021)

The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma
por: Yang, Jing, et al.
Publicado: (2019)

Predictive Value of Ultrasound Characteristics for Disease-Free Survival in Breast Cancer
por: Guo, Qiang, et al.
Publicado: (2022)

Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
por: Yang, Jing, et al.
Publicado: (2018)

Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis
por: Cullinane, Carolyn, et al.
Publicado: (2020)

Integrative Models of Histopathological Image Features and Omics Data Predict Survival in Head and Neck Squamous Cell Carcinoma
por: Zeng, Hao, et al.
Publicado: (2020)

Histopathological Images and Multi-Omics Integration Predict Molecular Characteristics and Survival in Lung Adenocarcinoma
por: Chen, Linyan, et al.
Publicado: (2021)

Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS
por: Yang, Jing, et al.
Publicado: (2017)

Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma
por: Zeng, Hao, et al.
Publicado: (2021)

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)

The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
por: Basnet, Shiva, et al.
Publicado: (2016)

Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis
por: Li, Yong, et al.
Publicado: (2021)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

The value of narrow band imaging in diagnosis of head and neck cancer: a meta-analysis
por: Zhou, Hui, et al.
Publicado: (2018)

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer
por: Hyun, Myung Han, et al.
Publicado: (2017)

Clinical value of peripheral blood circulating tumor DNA in predicting the efficacy of immunotherapy for non-small cell lung cancer
por: Wang, Jing, et al.
Publicado: (2023)

Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients
por: Xu, Xiaojing, et al.
Publicado: (2020)

Predictive value of radiomics-based machine learning for the disease-free survival in breast cancer: a systematic review and meta-analysis
por: Lu, Dongmei, et al.
Publicado: (2023)

Discrimination of Pancreatic Serous Cystadenomas From Mucinous Cystadenomas With CT Textural Features: Based on Machine Learning
por: Yang, Jing, et al.
Publicado: (2019)

Prognostic significance of inflammation-based indexes in patients with stage III/IV colorectal cancer after adjuvant chemoradiotherapy
por: Yang, Jing, et al.
Publicado: (2019)

Prognostic value of consolidation-to-tumor ratio on computed tomography in NSCLC: a meta-analysis
por: Wu, Yongming, et al.
Publicado: (2023)

Survival Prediction in Gallbladder Cancer Using CT Based Machine Learning
por: Liu, Zefan, et al.
Publicado: (2020)

Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma: A Meta-Analysis
por: Liao, Wenjun, et al.
Publicado: (2015)

Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis
por: Luo, Jie, et al.
Publicado: (2014)

The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis
por: Wang, Manni, et al.
Publicado: (2016)

Noninvasive prediction of response to cancer therapy using promoter profiling of circulating cell‐free DNA
por: Guo, Zhi‐Wei, et al.
Publicado: (2020)

High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survival
por: Kujala, Jouni, et al.
Publicado: (2020)

The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer
por: Riethdorf, Sabine, et al.
Publicado: (2017)

Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
por: Cavallone, Luca, et al.
Publicado: (2020)

Meta-Analysis of the Diagnostic Value of Cell-free DNA for Renal Cancer
por: Xu, Yipeng, et al.
Publicado: (2021)

The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis
por: Lu, Yan-jun, et al.
Publicado: (2016)

Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence
por: Cheng, Jie, et al.
Publicado: (2017)

Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma
por: Chen, Linyan, et al.
Publicado: (2021)

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
por: Varkaris, Andreas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8r2am4fqt9mkmltufrtakv0k76